Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Higher vs. lower haemoglobin threshold for transfusion in septic shock: subgroup analyses of the TRISS trial.

Rygård SL, Holst LB, Wetterslev J, Johansson PI, Perner A; TRISS trial group.; Scandinavian Critical Care Trials Group..

Acta Anaesthesiol Scand. 2017 Feb;61(2):166-175. doi: 10.1111/aas.12837. Epub 2016 Dec 2.

PMID:
27910086
2.

Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial.

Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettilä V, Aaen A, Lodahl D, Berthelsen RE, Christensen H, Madsen MB, Winkel P, Wetterslev J, Perner A; CLASSIC Trial Group.; Scandinavian Critical Care Trials Group..

Intensive Care Med. 2016 Nov;42(11):1695-1705. Epub 2016 Sep 30.

PMID:
27686349
3.

Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial.

Rygård SL, Holst LB, Wetterslev J, Winkel P, Johansson PI, Wernerman J, Guttormsen AB, Karlsson S, Perner A; TRISS Trial Group.; Scandinavian Critical Care Trials Group..

Intensive Care Med. 2016 Nov;42(11):1685-1694. Epub 2016 Sep 30.

PMID:
27686345
4.

Shock treatment in a cohort of Scandinavian intensive care units in 2014.

Kollind M, Wickbom F, Wilkman E, Snäckestrand MS, Holmén A, Oldner A, Perner A, Åneman A, Chew MS; Scandinavian Critical Care Trials Group..

Acta Anaesthesiol Scand. 2016 Aug;60(7):945-57. doi: 10.1111/aas.12745. Epub 2016 Jun 12.

PMID:
27291070
5.

Lower versus higher hemoglobin threshold for transfusion in septic shock.

Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, Johansson PI, Aneman A, Vang ML, Winding R, Nebrich L, Nibro HL, Rasmussen BS, Lauridsen JR, Nielsen JS, Oldner A, Pettilä V, Cronhjort MB, Andersen LH, Pedersen UG, Reiter N, Wiis J, White JO, Russell L, Thornberg KJ, Hjortrup PB, Müller RG, Møller MH, Steensen M, Tjäder I, Kilsand K, Odeberg-Wernerman S, Sjøbø B, Bundgaard H, Thyø MA, Lodahl D, Mærkedahl R, Albeck C, Illum D, Kruse M, Winkel P, Perner A; TRISS Trial Group.; Scandinavian Critical Care Trials Group..

N Engl J Med. 2014 Oct 9;371(15):1381-91. doi: 10.1056/NEJMoa1406617. Epub 2014 Oct 1.

6.

Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial.

Wittbrodt P, Haase N, Butowska D, Winding R, Poulsen JB, Perner A; 6S trial group.; Scandinavian Critical Care Trials Group..

Crit Care. 2013 Feb 25;17(2):R58. doi: 10.1186/cc12586.

7.

Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.

Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group.; Scandinavian Critical Care Trials Group..

N Engl J Med. 2012 Jul 12;367(2):124-34. doi: 10.1056/NEJMoa1204242. Epub 2012 Jun 27. Erratum in: N Engl J Med. 2012 Aug 2;367(5):481.

8.

Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patients.

Wernerman J, Kirketeig T, Andersson B, Berthelson H, Ersson A, Friberg H, Guttormsen AB, Hendrikx S, Pettilä V, Rossi P, Sjöberg F, Winsö O; Scandinavian Critical Care Trials Group..

Acta Anaesthesiol Scand. 2011 Aug;55(7):812-8. doi: 10.1111/j.1399-6576.2011.02453.x. Epub 2011 Jun 9.

PMID:
21658010
9.

Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial.

Perner A, Haase N, Wetterslev J, Aneman A, Tenhunen J, Guttormsen AB, Klemenzson G, Pott F, Bødker KD, Bådstøløkken PM, Bendtsen A, Søe-Jensen P, Tousi H, Bestle M, Pawlowicz M, Winding R, Bülow HH, Kancir C, Steensen M, Nielsen J, Fogh B, Madsen KR, Larsen NH, Carlsson M, Wiis J, Petersen JA, Iversen S, Schøidt O, Leivdal S, Berezowicz P, Pettilä V, Ruokonen E, Klepstad P, Karlsson S, Kaukonen M, Rutanen J, Karason S, Kjældgaard AL, Holst LB, Wernerman J; Scandinavian Critical Care Trials Group..

Trials. 2011 Jan 27;12:24. doi: 10.1186/1745-6215-12-24.

10.

Immediate and 5-year cumulative outcome after paediatric intensive care in Sweden.

Gullberg N, Kalzén H, Luhr O, Göthberg S, Winsö O, Markström A, Olsson AK, Frostell C; Scandinavian Critical Care Trials Group..

Acta Anaesthesiol Scand. 2008 Sep;52(8):1086-95. doi: 10.1111/j.1399-6576.2008.01711.x.

PMID:
18840109
11.

Survey of routines for sedation of patients on controlled ventilation in Nordic intensive care units.

Guldbrand P, Berggren L, Brattebö G, Mälstam J, Rönholm E, Winsö O; Scandinavian Critical Care Trials Group..

Acta Anaesthesiol Scand. 2004 Sep;48(8):944-50.

PMID:
15315610
12.

A practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units.

Oldner A, Rossi P, Karason S, Aneman A; Scandinavian Critical Care Trials Group..

Acta Anaesthesiol Scand. 2003 Jul;47(6):693-701.

PMID:
12803586

Supplemental Content

Loading ...
Support Center